Ligand Pharmaceuticals | LGND - Dochód Netto





Dochód Netto Zmiana Data
Agenus USD 39.17M 49.8M 2026-03
Amgen USD 2.38B 556M 2026-06
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
Baxter International USD 126M 141M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Enviri Corporation USD -84.28M 61.97M 2025-12
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Glaxosmithkline GBP 1.74B 890.94M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD 48.51M 61.85M 2026-06
MacroGenics USD -36.77M 22.62M 2026-03
Merck USD -1.34B 2.9B 2026-06
Pacira USD 4.65M 1.74M 2026-06
Pfizer USD -248M 2.94B 2026-06
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 25.49M 3.22M 2026-06